Quotient Sciences
“Quotient Sciences’ integrated approach to drug development accelerates molecules to IND & beyond”

Impressions: 847

This week, SpeakPharma interviews Eleanor Row, Executive Director of Commercial at Quotient Sciences, a global drug development accelerator with state-of-the-art development, manufacturing and clinical testing facilities in the US and UK. Over the l...


SpeakPharma with Quotient Sciences
15 May 2023
“For orphan drugs, we identify a patient-ready formulation in less than half the time.”

Impressions: 4185

This week, SpeakPharma interviews Dr. Peter Scholes, Chief Scientific Officer, Quotient Sciences, who talks about orphan drugs and some of the challenges drug developers face while developing them. In particular, Dr. Scholes tells us how Quotient Sc...


#SpeakPharma with Quotient Sciences
08 Feb 2021